1a), accompanied by impaired mitochondrial respiration as one of the main adverse molecular events (Suppl
Our team is always available to discuss potential benefits, address concerns, and provide the insights needed to understand how these treatments may fit into your overall recovery strategy
A few points that stood out to me: Indias anti-obesity market is already 1,000+ crore It has grown almost 10-fold in just 5 years GLP-1 medicines for obesity and diabetes are seeing wider access Obesity is now being treated as a chronic disease, not just a lifestyle issue AI and digital technologies are speeding up drug discovery and personalised care India is slowly moving beyond generics into biosimilars and complex biologics What I liked is the shift in thinking from quick fixes to patient-centric, long-term solutions for lifestyle diseases
Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist
Sitting is easier than standing for people with spinal stenosis
However, excessive overtraining without adequate recovery can actually deplete glutathione, so balance is key
